The global sleep apnea devices market size was USD 6.19 billion in 2023, estimated at USD 6.64 billion in 2024 and is anticipated to reach around USD 13.18 billion by 2034, expanding at a CAGR of 7% from 2024 to 2034.
The global sleep apnea devices market size accounted for USD 6.64 billion in 2024 and is predicted to reach around USD 13.18 billion by 2034, growing at a notable CAGR of 7% from 2024 to 2034.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. sleep apnea devices market size was valued at USD 2.09 billion in 2023 and is expected to be worth around USD 4.56 billion by 2036, poised to grow at a CAGR of 7.18% from 2024 to 2034.
At present, geographically, North America conquers the global sleep apnea devices market and is projected to endure its stronghold in near future. This enormous growth is attributed to the great prevalence of sleep-disordered breathing and increasing aged population in this region. As per Sleep Zone, it was projected that about 22 million Americans undergo from moderate to severe sleep apnea, among them, about 3 to 7% of men and 2 to 5% of women were recognize to have had sleep apnea in the U.S in 2018.
Nevertheless, Asia Pacific is assessed to exhibit highest CAGR during estimate period on account of snowballing occurrence of sleep apnea illnesses in this region, and deliberate agreements of international market front-runners with local companies. Additionally, huge undiagnosed pool in nations such as India, and initiatives undertaken by the government and other private administrations to promote awareness concerning sleep disorders is projected to further push the market growth in this region.
Several influences including an enormous pool of undiagnosed patients suffering from sleep apnea, mounting utilization of oral appliances, and technological advancements in sleep apnea devices are flourishing the growth of the global sleep apnea market.
Substantial venture capital finance, cumulative number of establishments volunteering into sleep apnea and oral appliances sector is expected to upsurge the market demand during near future. Additionally, escalating pervasiveness of obstructive sleep apnea at a worldwide level is estimated to significantly push sale of sleep apnea devices during years to come.
Global sleep apnea market is expected to record optimistic growth due to several probable advantages presented by mHealth and telemedicine in improving sleep apnea management and diagnosis. Numerous studies have stated that a foremost projecting aspect for long-term CPAP compliance is patient observance in the first few weeks of treatment. In order to advance compliance, follow-up and support throughout this period must be quick. Telemedicine provides such sort of support since extended waiting lists make it problematic to deliver this support. Many studies recommend that patients in the telemedicine group conveyed high satisfaction with their care and specifically enjoyed the suitability of a live video visit with doctor and consultant.
Report Highlights | Details |
Market Size in 2023 | USD 6.19 Billion |
Market Size in 2024 | USD 6.64 Billion |
Market Size by 2034 | USD 13.18 Billion |
Growth Rate from 2024 to 2034 | CAGR of 7% |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Product Type, End-User Type, and Region |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Among different product segments analyzed in this report, therapeutic devices led the market in 2023 with majority of the revenue share. This development is credited to augmented disease consciousness amid patients, obtainability of technologically enhanced products, and intensifying market competition.
Further, PAP devices sub-segment is assessed to see noteworthy growth throughout assessment period. This great growth is accredited to mounting requirement for competent, superior and transportable sleep apnea devices. Moreover, existence of satisfactory insurance coverage for management of sleep apnea and other sleep disorders would supplement demand for PAP devices worldwide. Growing commonness of sleep apnea and associated co-morbidities in numerous parts of the globe is a foremost influence heightening the importance of polysomnography devices. Furthermore, intensify ingresponsiveness for sleep apnea and other sleep disorders among the populace will further add to their market growth.
Different end-use sectors assessed in this research report include diagnostic devices and therapeutic devices. The assortment of devices employed in hospitals and sleep laboratories is restricted mostly to diagnostic devices including tabletop pulse oximeters, actigraphy systems, and clinical PSG devices. There is a progression in the number of sleep tests and labs accomplished with the help of a clinical polysomnography device across the world, as these tests are being assumed the standard diagnostic test for sleep apnea since long time period.
Segments Covered in the Report
By Product Type
By End-User
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sleep Apnea Devices Market
5.1. COVID-19 Landscape: Sleep Apnea Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sleep Apnea Devices Market, By Product Type
8.1. Sleep Apnea Devices Market, by Product Type, 2024-2034
8.1.1. Diagnostic Devices
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Therapeutic Devices
8.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Sleep Apnea Devices Market, By End-User
9.1. Sleep Apnea Devices Market, by End-User, 2024-2034
9.1.1. Home Care Setting
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Sleep Laboratories & Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Sleep Apnea Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.1.2. Market Revenue and Forecast, by End-User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.1.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.1.4.2. Market Revenue and Forecast, by End-User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.2.2. Market Revenue and Forecast, by End-User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.2.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.2.4.2. Market Revenue and Forecast, by End-User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.2.5.2. Market Revenue and Forecast, by End-User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.2.6.2. Market Revenue and Forecast, by End-User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.3.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.3.4.2. Market Revenue and Forecast, by End-User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.3.5.2. Market Revenue and Forecast, by End-User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.3.6.2. Market Revenue and Forecast, by End-User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.4.2. Market Revenue and Forecast, by End-User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.4.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.4.4.2. Market Revenue and Forecast, by End-User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.4.5.2. Market Revenue and Forecast, by End-User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.4.6.2. Market Revenue and Forecast, by End-User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.5.2. Market Revenue and Forecast, by End-User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.5.3.2. Market Revenue and Forecast, by End-User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
10.5.4.2. Market Revenue and Forecast, by End-User (2021-2034)
Chapter 11. Company Profiles
11.1. GE Healthcare
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. BMC Medical
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Philips Healthcare
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Weinmann Medical Devices
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. CadwellLaboratorie
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Compumedics
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Curative Medical
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Teleflex
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. CareFusion Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Fisher &Paykel Healthcare
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client